Neumora Therapeutics, Inc. (NMRA) Institutional Ownership

Ownership Summary

Neumora Therapeutics, Inc. (NASDAQ:NMRA) appears in 114 institutional 13F filings for the quarter ending March 2026.

• Their combined ownership stood at 39.2% of outstanding shares in March 2026, down from 40.4% in December 2025.
• Their total shares held in NMRA increased 17.61% quarter over quarter, and separately, investors owning Neumora Therapeutics decreased 2.56% from a year ago.
• Of these 114 funds, 60 grew their exposure to Neumora Therapeutics, 33 cut back, and 21 maintained positions.
• Altogether, these fund groups held 70.48Mn shares in NMRA by March 2026, up by 10.55Mn shares quarter on quarter, and up 710.53K shares year over year.
• Siren, L.L.C. is the top holder of Neumora Therapeutics as of March 31, 2026, with 8.5Mn shares representing 4.72% of outstanding stock.
• The largest buyers of Neumora Therapeutics for the quarter ending March 2026 were PERCEPTIVE ADVISORS LLC (5.1Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.89Mn), Siren, L.L.C. (2.21Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.0Mn), SILVERARC CAPITAL MANAGEMENT, LLC (818.16K).
• Leading sellers of Neumora Therapeutics shares for the quarter ending March 2026 were Point72 Asset Management, L.P. (3.07Mn), Johnson & Johnson (1.85Mn), Goldman Sachs Group Inc (1.15Mn), MILLENNIUM MANAGEMENT LLC (861.66K), TANG CAPITAL MANAGEMENT LLC (527.36K).
• Neumora Therapeutics's 10 largest shareholders as of March 2026 include Siren, L.L.C. (8.5Mn), SOFTBANK GROUP CORP. (6.09Mn), PERCEPTIVE ADVISORS LLC (5.1Mn), MIC Capital Management UK LLP (4.46Mn), VANGUARD CAPITAL MANAGEMENT LLC (3.89Mn), FMR LLC (3.5Mn), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (3.31Mn), MILLENNIUM MANAGEMENT LLC (2.75Mn), ICONIQ Capital, LLC (2.56Mn), Lunate Capital Ltd (2.12Mn) per Business Quant data.